$636,815
＋16.2%
Chief Financial Officer and Chief Operating Officer
2024
$602k org
40 hrs/wk
$36k other
--
Chief Financial Officer and Chief Operating Officer at New York Stem Cell Foundation Inc.
Fiscal year ended June 30, 2024. Published on January 25, 2026.
Total compensation
Jeffrey Wallerstein has been listed as an employee of New York Stem Cell Foundation Inc. in Form 990 filings since fiscal year 2018. Total compensation for Jeffrey Wallerstein has increased by 47.5% from 2018 to 2024.